Palonosetron for prevention of acute and delayed nausea and vomiting induced by moderately emetogenic adjuvant folfox-4 regimen in colorectalcancer(CRG)patients: A phase II study of the Gruppo Oncologico dell' Italia Meridionale (GOIM)